definiens: means inventions, information and technology comprising nucleic acid sequences associatedwith single mutation arrhythmias that are discovered or identified by or on behalf of FSM as of or after the EffectiveDate, as well as methods of making or using such sequences, methods of administering such sequences to cells ortissues, and compositions and methods necessary or useful to practice the foregoing . Improvements will includewithout 2limitation inventions, information and technology relating to arrhythmogenic syndromes, including without limitationrecessive CPVT, dominant CPVT, short QT, dominant LQTS, recessive LQTS, Brugada, right ventricularcardiomyopathy, lamin A / C cardiomyopathy and dilated cardiomyopathy . For clarity, FSM shall have no obligation tofund research to identify Improvements, and may seek grants from non - profit entities in connection with FSM ’s effortsto discover or identify Improvements